The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna

BMC Women's Health

Volumn 10, Issue , 2010, Pages

  Cardini, Francesco ^a   Lesi, Grazia ^b   Lombardo, Flavia ^c   van der Sluijs, Corinne ^d  

^a Agency for Health and Social Care of Emilia Romagna   (Italy)

^b Local Health Unit   (Italy)

^c Italian National Health Institute   (Italy)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EMPLOYMENT OF WOMEN; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HEALTH CARE UTILIZATION; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; INTERPERSONAL COMMUNICATION; ITALY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; PATIENT SAFETY; PHYSICIAN; WOMEN'S HEALTH; ATTITUDE TO HEALTH; CULTURAL FACTOR; DIET; ESTROGEN THERAPY; HERBAL MEDICINE; HOT FLUSH; LIFESTYLE; MASSAGE; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PREVALENCE; QUESTIONNAIRE; STATISTICS; UTILIZATION REVIEW;

AGED; ATTITUDE TO HEALTH; COMPLEMENTARY THERAPIES; CULTURAL CHARACTERISTICS; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH STATUS; HERBAL MEDICINE; HOT FLASHES; HUMANS; ITALY; LIFE STYLE; MASSAGE; MENOPAUSE; MIDDLE AGED; PHYTOTHERAPY; PREVALENCE; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 77949357056     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-10-7     Document Type: Article

References (28)

1. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996, 88:437-442. 10.1016/0029-7844(96)00196-2, 8752255.
2. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 2001, 4:58-74.
3. Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause 1999, 6:282-289. 10.1097/00042192-199906010-00017, 10614674.
4. Regan MM, Emond SK, Attardo MJ, Parker RA, Greenspan SL. Why do older women discontinue hormone replacement therapy?. J Womens Health Gend Based Med 2001, 10:343-350. 10.1089/152460901750269661, 11445025.
5. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. 10.1016/S0140-6736(03)14065-2, 12927427, Million Women Study Collaborators.
6. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D, . HERS REsearch Group Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002, 288:58-66. 10.1001/jama.288.1.58, 12090863, HERS REsearch Group.
7. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
8. Ettinger B, Grady D, Tosteson ANA, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003, 102:1225-1232. 10.1016/j.obstetgynecol.2003.08.007, 14662208.
9. Newton KM, Buist DSM, Keenan NL, Anderson LA, La Croix AZ. Use of alternative therapies for menopause symptoms: results of a population-based study. Obstet Gynecol 2002, 100:18-25. 10.1016/S0029-7844(02)02005-7, 12100799.
10. Mantyranta T, Hemminki E, Kangas I, Topo P, Uutela A. Alternative drug use for the climacteric in Finland. Maturitas 1997, 27:5-11. 10.1016/S0378-5122(97)01106-7, 9158072.
11. Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003, 10:507-515. 10.1097/01.GME.0000064865.58809.3E, 14627858.
12. Bair YA, Gold EB, Greendale GA, Sternfeld B, Adler SR, Azari R, Harkey M. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health 2002, 92:1832-1840. 10.2105/AJPH.92.11.1832, 1447337, 12406817.
13. Gollschewski S, Anderson D, Skerman H, Lyons-Wall P. The use of complementary and alternative medications by menopausal women in South East Queensland. Womens Health Issues 2004, 14:165-171.
14. Lloyd P, Lupton D, Wiesner D, Hasleton S. Choosing alternative therapy: an exploratory study of sociodemographic characteristics and motives of patients resident in Sydney. Australian Journal of Public Health 1993, 17:135-144.
15. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms: qualitative study of women's experiences. Canadian Family Physician 1998, 44:1271-1276. 2278270, 9640521.
16. Factor-Litvak P, Cushman LF, Kronenberg F, Wade C, Kalmuss D. Use of complementary and alternative medicine among women in New York City: A pilot study. The Journal of Alternative and Complementary Medicine 2001, 7:658-666.
17. Vashisht A, Domoney CL, Cronje W, Studd JWW. Prevalence of and satisfaction with complementary therapies and hormone replacement therapy in a specialist menopause clinic. Climacteric 2001, 4:250-256.
18. Cherrington A, Lewis CE, McCreath HE, Herman CJ, Richter DL, Bryrd T. Association of complementary and alternative medicine use, demographic factors, and perimenopausal symptoms in a multiethnic sample of women: the ENDOW study. Family and Community Health 2003, 26:74-84.
19. Sluijs C, Bensoussan A, Liyanage L, Shah S. Women's health during mid-life survey: the use of complementary and alternative medicine by symptomatic women transitioning through menopause in Sydney. Menopause 2007, 14:397-403. 10.1097/01.gme.0000236937.36078.f4, 17202872.
20. Biglia N, Cozzarella M, Ponzone R, Marenco D, Maggiorotto F, Fuso L, Sismondi P. Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy. Gynecol Endocrinol 2004, 18:165-74. 10.1080/09513590310001653026, 15255286.
21. Istituto Nazionale di Statistica Le terapie non convenzionali in Italia. Istituto Nazionale di Statistica., http://www.istat.it/salastampa/comunicati/non_calendario/20070821_00/
22. Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002, 58:61-4. 10.1007/s00228-002-0435-8, 11956675.
23. Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes; a systematic review and meta-analysis. Maturitas 2006, 55:203-211. 10.1016/j.maturitas.2006.03.008, 16675169.
24. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2007, 17(4):CD001395.
25. Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999, 19:870-876. 10.1592/phco.19.10.870.31558, 10417036.
26. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Annals of Pharmacotherapy 2002, 36:1893-1896. 10.1345/aph.1C160, 12452752.
27. Cockayne NL, Duguid M, Shenfield GM. Health professionals rarely record history of complementary and alternative medicines. Br J Clin Pharmacol 2004, 59:254-258.
28. Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, Davis RB. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001, 135:344-351.